Composition for treatment of dry eye disease and meibomianitis
AssigneeEpax Norway AS
InventorsHarald Breivik, Harald Svensen, Iren Merete Skjåstad Stoknes
Life of this patent
Estimating the term…
Abstract
The present application relates to compositions for treatment of eye disorders, particularly for treatment of dry eye disease (DED) and meibomianitis, wherein the composition comprises very long chain polyunsaturated fatty acids. Further, the invention provides a method for treatment of DED and meibomianitis of a subject, comprising administering to the subject a composition comprising very long chain polyunsaturated fatty acids derived from natural oils. The compositions for use are suitable for oral and local applications.
Claims21
A method for treatment of Dry Eye Disease (DED) or meibomianitis of a subject, the method comprising administering to the subject a composition comprising at least 1% by weight of a very long chain polyunsaturated fatty acid (VLCPUFA) having a chain length of more than 22 carbon atoms, wherein the VLCPUFA is derived from a natural oil selected from the group consisting of fish oil, squid oil, krill oil, copepod oil, and algal oil.
An ophthalmic formulation comprising a composition, wherein the composition comprises at least 5% by weight of a very long chain polyunsaturated fatty acid (VLCPUFA) having a chain length of more than 22 carbon atoms, wherein the VLCPUFA is derived from a natural oil selected from the group consisting of fish oil, squid oil, krill oil, copepod oil, and algal oil.
Dependencies are inferred from the claim text.